Cardiac fibrosis in the pressure overloaded left and right ventricle as a therapeutic target

K Schimmel, K Ichimura, S Reddy, F Haddad… - Frontiers in …, 2022 - frontiersin.org
Myocardial fibrosis is a remodeling process of the extracellular matrix (ECM) following
cardiac stress.“Replacement fibrosis” is a term used to describe wound healing in the acute …

[HTML][HTML] The impact of microbiota-derived short-chain fatty acids on macrophage activities in disease: Mechanisms and therapeutic potentials

H Duan, LJ Wang, M Huangfu, H Li - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Short-chain fatty acids (SCFAs) derived from the fermentation of carbohydrates by gut
microbiota play a crucial role in regulating host physiology. Among them, acetate …

Treatment targets for right ventricular dysfunction in pulmonary arterial hypertension

SZ Prisco, T Thenappan, KW Prins - Basic to Translational Science, 2020 - jacc.org
Right ventricle (RV) dysfunction is the strongest predictor of mortality in pulmonary arterial
hypertension (PAH), but, at present, there are no therapies directly targeting the failing RV …

The short-chain fatty acid butyrate attenuates pulmonary vascular remodeling and inflammation in hypoxia-induced pulmonary hypertension

V Karoor, D Strassheim, T Sullivan, A Verin… - International journal of …, 2021 - mdpi.com
Pulmonary hypertension (PH) is a progressive cardiovascular disorder in which local
vascular inflammation leads to increased pulmonary vascular remodeling and ultimately to …

Animal models of pulmonary hypertension: Getting to the heart of the problem

JP Dignam, TE Scott, BK Kemp‐Harper… - British Journal of …, 2022 - Wiley Online Library
Despite recent therapeutic advances, pulmonary hypertension (PH) remains a fatal disease
due to the development of right ventricular (RV) failure. At present, no treatments targeted at …

Pathophysiology of the right ventricle and its pulmonary vascular interaction

AR Hemnes, DS Celermajer, M D'Alto… - European …, 2024 - publications.ersnet.org
The right ventricle and its stress response is perhaps the most important arbiter of survival in
patients with pulmonary hypertension of many causes. The physiology of the …

[HTML][HTML] Molecular mechanisms and targets of right ventricular fibrosis in pulmonary hypertension

FT Bekedam, MJ Goumans, HJ Bogaard… - Pharmacology & …, 2023 - Elsevier
Right ventricular fibrosis is a stress response, predominantly mediated by cardiac
fibroblasts. This cell population is sensitive to increased levels of pro-inflammatory …

Improving right ventricular function by increasing BMP signaling with FK506

M Boehm, X Tian, MK Ali, Y Mao… - American Journal of …, 2021 - atsjournals.org
Right ventricular (RV) function is the predominant determinant of survival in patients with
pulmonary arterial hypertension (PAH). In preclinical models, pharmacological activation of …

GPx3 deficiency exacerbates maladaptive right ventricular remodeling in experimental pulmonary artery banding

TA Covington, PM Pilz, RM Mulhern… - … of Physiology-Lung …, 2023 - journals.physiology.org
The stressed right ventricle (RV) is particularly susceptible to producing and accumulating
reactive oxygen species, leading to extracellular matrix deposition and secretion of …

[HTML][HTML] Emerging therapies for right ventricular dysfunction and failure

A Klinke, T Schubert, M Müller… - Cardiovascular …, 2020 - ncbi.nlm.nih.gov
Therapeutic options for right ventricular (RV) dysfunction and failure are strongly limited.
Right heart failure (RHF) has been mostly addressed in the context of pulmonary arterial …